NISA INVESTMENT ADVISORS, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$141,605
+73.4%
5,270
+130.1%
0.00%0.0%
Q2 2023$81,661
+160019.6%
2,290
+14.2%
0.00%
Q1 2023$51
-83.6%
2,005
-73.8%
0.00%
-100.0%
Q4 2022$311
-99.9%
7,667
+1.9%
0.00%0.0%
Q3 2022$253,000
-1.9%
7,526
+2.8%
0.00%0.0%
Q2 2022$258,000
+24.0%
7,324
+61.9%
0.00%
+100.0%
Q1 2022$208,000
-41.4%
4,524
-32.8%
0.00%
-66.7%
Q4 2021$355,000
-42.6%
6,734
-32.0%
0.00%
-25.0%
Q3 2021$618,000
-13.8%
9,904
+14.4%
0.00%0.0%
Q2 2021$717,000
+40.3%
8,658
+12.3%
0.00%
+33.3%
Q1 2021$511,000
-11.9%
7,708
+2.0%
0.00%
-25.0%
Q4 2020$580,000
+147.9%
7,558
+39.1%
0.00%
+100.0%
Q3 2020$234,000
+69.6%
5,435
+70.6%
0.00%
+100.0%
Q2 2020$138,000
-45.5%
3,185
-63.8%
0.00%
-66.7%
Q1 2020$253,000
-65.2%
8,810
-23.0%
0.00%
-50.0%
Q4 2019$726,000
+2403.4%
11,440
+1021.6%
0.01%
Q3 2019$29,000
+107.1%
1,020
+96.2%
0.00%
Q2 2019$14,000
+40.0%
5200.0%0.00%
Q1 2019$10,000
+66.7%
5200.0%0.00%
Q4 2018$6,000
-40.0%
5200.0%0.00%
Q3 2018$10,000
+42.9%
520
-86.3%
0.00%
Q1 2017$7,0003,8000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders